Stocks Blog: Hang Seng turns up on reports of US, China deal to remove extra tariffs in phases

  • CK Life Sciences market valuation passes HK$10 billion
  • CSPC Pharmaceutical rises 4.4 per cent 
Investors have turned their attention to innovative drug development. CK Life Sciences is one company whose shares have shot up. Above, a scientist transfers fluids into a tube at the Driver laboratory in Shantou, China. Photo: China
Topic |   Stocks Blog